Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
30.2M
-
Shares change
-
+2.34M
-
Total reported value, excl. options
-
$929M
-
Value change
-
+$79.2M
-
Put/Call ratio
-
1.54
-
Number of buys
-
83
-
Number of sells
-
-39
-
Price
-
$30.73
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q4 2017
171 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q4 2017.
Editas Medicine, Inc. - Common Stock (EDIT) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.2M shares
of 82.8M outstanding shares and own 36.5% of the company stock.
Largest 10 shareholders include FMR LLC (4.62M shares), Vanguard Group Inc (2.77M shares), BlackRock Inc. (2.67M shares), STATE STREET CORP (2.41M shares), Capital World Investors (1.77M shares), Viking Global Investors LP (1.71M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.71M shares), Flagship Pioneering Inc. (1.67M shares), ARK Investment Management LLC (1.11M shares), and TRV GP III, LLC (906K shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.